Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4832931, 6 pages
https://doi.org/10.1155/2017/4832931
Review Article

miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma

1Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, 10 East China Road, Nanning, Guangxi Zhuang Autonomous Region, China
2The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China

Correspondence should be addressed to JinYu Wu; moc.anis@9010uynijuw

Received 29 May 2017; Accepted 17 September 2017; Published 17 December 2017

Academic Editor: Francesco Marampon

Copyright © 2017 LongJiao Ran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L.-M. Krabbe, A. Bagrodia, V. Margulis, and C. G. Wood, “Surgical management of renal cell carcinoma,” Seminars in Interventional Radiology, vol. 31, no. 1, pp. 27–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Li, G. Zhang, X. Zhang et al., “Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression,” Medical oncology (Northwood, London, England), vol. 31, no. 12, p. 349, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Yang, X. Zhou, S. Du et al., “LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer,” PLoS ONE, vol. 9, no. 6, Article ID e100557, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Teng, Y. Gao, M. Chen et al., “Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma,” Chinese Medical Journal, vol. 127, no. 9, pp. 1640–1644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Fan, J. Huang, H. Xiao, and Z. Liang, “MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN,” Molecular Medicine Reports, vol. 13, no. 6, pp. 4800–4806, 2016. View at Publisher · View at Google Scholar
  6. F.-Q. Yang, H.-M. Zhang, S.-J. Chen, Y. Yan, and J.-H. Zheng, “Correction: MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1,” PLoS ONE, vol. 10, no. 5, Article ID e0129404, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Chen, X. Wang, A. Ruan et al., “MiR-141 Is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression,” Clinical Cancer Research, vol. 20, no. 10, pp. 2617–2630, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Lou, A.-M. Ruan, B. Qiu et al., “miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma,” Urologic Oncology: Seminars and Original Investigations, vol. 35, no. 1, pp. 36.e7–36.e14, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. H. W. Khella, A. Scorilas, R. Mozes et al., “Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma,” The American Journal of Pathology, vol. 185, no. 3, pp. 693–703, 2015. View at Publisher · View at Google Scholar
  10. R. Nofech-Mozes, H. W. Z. Khella, A. Scorilas et al., “MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma,” Cancer Medicine, vol. 5, no. 4, pp. 656–664, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Xiao, W. Xiao, J. Cao et al., “MiR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma,” Cancer Letters, vol. 374, no. 1, pp. 107–116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Niu, X. Ma, Y. Zhang et al., “Expression of miR-223 in clear cell renal cell carcinoma and its significance,” Journal of Southern Medical University, vol. 35, no. 3, pp. 338–342, 2015. View at Google Scholar · View at Scopus
  13. Y.-Z. Ge, R. Wu, H. Xin et al., “A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 7, pp. 1291–1299, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Ishihara, N. Seki, S. Inoguchi et al., “Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma,” The Journal of Urology, vol. 192, no. 6, pp. 1822–1830, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Xu, J. Zhu, Z. Lei et al., “Expression and functional role of miR-29b in renal cell carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 11, pp. 14161–14170, 2015. View at Google Scholar
  16. Q. Fu, Z. Liu, D. Pan et al., “Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection,” Cancer Science, vol. 105, no. 11, pp. 1427–1434, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Gebauer, I. Peters, N. Dubrowinskaja et al., “Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma,” British Journal of Cancer, vol. 108, no. 1, pp. 131–138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Nakata, M. Uemura, M. Sato et al., “Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma,” Oncotarget , vol. 6, no. 25, pp. 21645–21654, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. B. Huang, X. Ma, X. Zhang et al., “Down-regulated miR-30a in clear cell renal cell carcinoma correlated with tumor hematogenous metastasis by targeting angiogenesis-specific DLL4,” PLoS ONE, vol. 8, no. 6, Article ID e67294, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Li, M. Liu, Y. Feng et al., “Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).,” British Journal of Cancer, vol. 111, no. 6, pp. 1188–1200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Heinzelmann, A. Unrein, U. Wickmann et al., “MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases,” Annals of Surgical Oncology, vol. 21, no. 3, pp. 1046–1054, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Wotschofsky, J. Busch, M. Jung et al., “Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy,” Clinica Chimica Acta, vol. 416, pp. 5–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Samaan, H. W. Z. Khella, A. Girgis et al., “MiR-210 is a prognostic marker in clear cell renal cell carcinoma,” Journal of Molecular Diagnostics, vol. 17, no. 2, pp. 136–144, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Xu, M. Gu, K. Zhang, J. Zhou, Z. Wang, and J. Da, “miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2,” Diagnostic Pathology, vol. 10, article 24, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Zhao, Z. Zhao, W. Xu, J. Hou, and X. Du, “Down-regulation of miR-497 is associated with poor prognosis in renal cancer,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 1, pp. 758–764, 2015. View at Google Scholar
  26. J. J. Zhao, P. J. Chen, R. Q. Duan, K. J. Li, Y. Z. Wang, and Y. Li, “Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 3318–3323, 2014. View at Google Scholar
  27. H. Li, J. Zhao, J. W. Zhang et al., “MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration,” Neoplasma, vol. 60, no. 5, pp. 511–515, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Zhao, T. Lei, C. Xu et al., “MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3,” Biochemical and Biophysical Research Communications, vol. 438, no. 2, pp. 439–444, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Chen, A. Ruan, X. Wang et al., “miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes,” Journal of Cancer Research and Clinical Oncology, vol. 140, no. 8, pp. 1295–1304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Vergho, S. Kneitz, A. Rosenwald et al., “Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma,” BMC Cancer, vol. 14, no. 1, article no. 25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. H. K. M. Fritz, D. Lindgren, B. Ljungberg, H. Axelson, and B. Dahlbäck, “The miR21/10b ratio as a prognostic marker in clear cell renal cell carcinoma,” European Journal of Cancer, vol. 50, no. 10, pp. 1758–1765, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Liep, E. Kilic, H. A. Meyer, J. Busch, K. Jung, and A. Rabien, “Cooperative effect of miR-141-3p and miR-145-5p in the regulation of targets in clear cell renal cell carcinoma,” PLoS ONE, vol. 11, no. 6, Article ID 0157801, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. D. C. Vergho, S. Kneitz, C. Kalogirou et al., “Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava,” PLoS ONE, vol. 9, no. 10, Article ID e109877, 2014. View at Publisher · View at Google Scholar